Click Here To See Our SMASH2006 Special Offers! |
Coupling Constants Links to What's New in Capillary NMR |
||
Protasis is committed to connecting life science researchers to innovative new microtechnologies. |
|||
December, 2006 © Protasis |
|||
NMR Front Page News |
Featured Abstract |
||
Quick! Go to: http://www.spectroscopynow.com/ Microcoils boost NMR. Current capillary NMR technology is reviewed, including its applications for the characterization of mass-limited, small-molecule and protein samples and the rapid screening of small-molecule or protein libraries. Hyphenated techniques are also covered. [December 5, 2006] Protasis is pleased to make the cover of spectroscopyNOW.com this month with a nice introduction to Capillary NMR in a ten-page review article published recently in Angewandte Chemie Int. Ed. by Frank Schroeder and Matthew Gronquist.Want a reprint of the entire review article? Click here. We'll send it. |
Extending the Scope
of NMR
Spectroscopy
with
Microcoil Probes
by Frank C. Schroeder, Harvard Medical
School
and Matthew Gronquist, SUNY College at
Fredonai
Capillary NMR spectroscopy has emerged as a major breakthrough for increasing the mass-sensitivity of NMR spectroscopic analysis and enabling the combination of NMR spectroscopy with other analytical techniques. Not only is the acquisition of high-sensitivity spectra getting easier, but the quality of CapNMR spectra obtained in many small-molecule applications exceeds what can be accomplished with conventional designs. This Minireview discusses current CapNMR technology and its applications for the characterization of mass-limited, small molecule and protein samples, the rapid screening of small-molecule and protein samples, the rapid screening of small-molecule or protein libraries, as well as hyphenated techniques that combine CapNMR with other analytical techniques. |
||
See the related 2005 journal paper by Frank Schroeder, et al. And see the 2005 'Firefly' press release in Royal Soc. Chem. | |||
Join Our Next e-Seminar Bringing Nature Back to Drug Discovery, by Mark O'Neil-Johnson, Sequoia Sciences, St. Louis | SMASH Wrap-Up September, 10 - 13th Burlington, VT | ||
Please register at:
http://www.protasis.com/seminar/WhatsNew2006/ |
See all the SMASH 2006 Highlights at the e-Seminar on December 13th! | ||
Date : December 13, 2006 Time : 3:30 PM EST |
|||
Protasis Corporation is pleased to present an e-seminar
on Wednesday, Dec. 13th from |
We typically use the fall SMASH conference to check-in with our customers and learn about new trends in small molecule NMR and this year was no exception. Tim Peck, Bob Albrecht and Dave Strand were there with a CTC/LEAP liquid handler demonstrating the robotics, fluidics and software for our record-setting One-Minute NMR platforms. About twenty of our current customers visited with us over the four days that we were there. Some of these users are running hundreds of samples per month and supporting dozens of synthesis chemists to create smooth-running, trouble-free departmental Open-Access HT-NMR automation systems. We interviewed these customers and gave them a demo of the latest One-Minute NMR software. To hear what they told us, request our SMASH 2006 Wrap-Up Letter. Request Wrap-Up Letter and Info Package Request Poster | ||
Sequoia Sciences was founded to deliver to the drug discovery process a structurally diverse library of natural products isolated from plants. The proprietary design of this library allows the screening of these compounds at optimal HTS concentrations without non-drug-like interferences. In order to facilitate the rapid identification of potential leads, Sequoia has built an analytical process that can facilitate the rapid isolation and structure elucidation of active compounds. Paramount to the success of our structure elucidation efforts, Sequoia has relied solely on NMR data acquisition using the Protasis’ remarkable CapNMR™ probe. Moreover, we have applied our proprietary chemistry procedures and innovative technologies in our internal antibacterial program, discovering a variety of compounds that show promising inhibition of bacterial biofilms and are synthetically accessible. | |||
View Full Announcement
Contact David Strand at 508-481-4163 or by email at d.strand@protasis for questions or additional details. |
See Protasis SMASH Special Offers
|
||